subgroup of
vitamin c)
→
ReceivesAction
→
studied as treatment
| Typicality: | 0.250 |
| Saliency: | 0.000 |
| for patients with cancer | 3 | transitive-object |
| since the 1970s | 2 | temporal |
| high dose vitamin c → be studied as → treatment | 3 |
| negative | neutral | positive |
| 0.031 | 0.795 | 0.174 |
| Raw frequency | 3 |
| Normalized frequency | 0.000 |
| Modifier score | 0.500 |
| Perplexity | 21.366 |